Stents

July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the company's latest-generation bare-metal stent for the treatment of coronary artery d...

April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the company's Absorb bioresorbable vascular scaffold (BVS) in the United States, Japan and China. Combined, the U.S., Japan and China ac...

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo Corp. Under the agreement, ART and Terumo Corp. will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended...

July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system...
stentys, stent, self-apposing stent
Stentys has announced the publication of an article in the Journal of the American College of Cardiology (JACC) entitled, "Causes of Early Stent Thrombosis in...
July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued a patent related to Micell's technology for...
July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and Blood Institute (NHLBI) to continue the...
Boston Scientific received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the
The Flash Ostial System Dual Balloon Angioplasty Catheter system is designed to help overcome the challenges of aorto-ostial stenting...
Micell Technologies Inc.'s thin-strut stent features elimination of the coating from the stent in 45-60 days and the complete absorption of...

Articles

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience environment of healthcare reform, there needs to...
Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the transaction is completed, Medtronic will have significantly...
Strokes kill nearly 130,000 Americans every year, according to the Centers for Disease Control and Prevention. Because approximately 30 percent of strokes are...
Elixir Medical Corp. DESolve 100 CE mark
Elixir Medical Corp. received CE mark approval for its DESolve 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
3 days 19 hours ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
2 weeks 5 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
3 weeks 4 days ago
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live...